• Profile
Close

Characterization of variables for potential impact on vancomycin pharmacokinetics in thermal or inhalation injury

Burns Nov 08, 2017

Elder K, et al. - This study is planned to assess the pharmacokinetics of vancomycin dosing in thermal or inhalation injury as they relate to percent total body surface area burn (TBSA) and days since injury (DSI). Authors suggest that DSI, percent TBSA, and Creatinine clearance (CrCl) may be predictive of faster vancomycin CL and need for higher total daily doses. Findings suggest the occurrence of augmented pharmacokinetics as early as two days after an injury that decreases with time. Acceptable target trough attainment is still lacking. Therefore, for initial vancomycin dosing, this data should assist in performance improvements.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay